Navigation Links
Optimer Pharmaceuticals' Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
Date:8/19/2010

esulted in greater awareness and concern of CDI among medical professionals and public health officials. Learn more about CDI at www.cdiinfo.org.

About Optimer PharmaceuticalsOptimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing hospital specialty products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI).  In two Phase 3 trials completed by Optimer to study the safety and efficacy of fidaxomicin for the treatment of CDI, fidaxomicin was statistically superior to vancomycin in global cure rate (defined as cure with no recurrence within four weeks of completing therapy) and reduced recurrences of CDI by up to 50% when compared with vancomycin, the only FDA approved product for CDI. Pruvel™ is a prodrug in the fluoroquinolone class of antibiotics being developed as a treatment for infectious diarrhea.  Optimer has also successfully completed two Phase 3 trials with Pruvel.  Additional information can be found at http://www.optimerpharma.com.

Forward Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements, including without limitation all statements related to the development of fidaxomicin, the incidence and effects of CDI, the efficacy of current CDI treatments and the efficacy and potential benefits of fidaxomicin, potential regulatory approval of fidaxomicin, the timing of an NDA filing for fidaxomicin, the impact of the validation of Optimer's fidaxomicin MAA on the value of fidaxomicin or Optimer's partnership efforts, Optimer's plans to commercialize fidaxomicin, if approved, the lik
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... HOUSTON , July 28, 2014  Houston ... announces that he offers orthodontic treatment with Invisalign. ... area patients can have their teeth straightened without ... same long-term benefits associated with other types of ... enjoy natural looks in addition to better support ...
(Date:7/28/2014)... , July 28, 2014 /PRNewswire/ ... in lifestyle healthcare and subsidiary of ... has acquired Physician Recommended Nutriceuticals (PRN) ® ... and related products for dry eye ... in a transaction worth up to ...
(Date:7/28/2014)... 28, 2014  ResMed (NYSE: RMD ), ... treatment of sleep-disordered breathing and other chronic respiratory conditions, ... against Taiwanese medical device manufacturer APEX Medical ... APEX WiZARD 210 and 220 masks.  The judgment was ... Munich , is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... YORK, Pa., June 29, 2011 Unilife Corporation ("Unilife" ... UNS) today announced that it has successfully completed the ... key industrial milestone represents the final step in the ... Alan Shortall, CEO of Unilife, said: "The completion of ...
... 29, 2011 Suneva Medical, a privately-held aesthetic ... its core aesthetics injectable business with approval from ... long lasting dermal filler for nasolabial folds or ... a unique, long-lasting treatment, Bellafill provides physicians the ...
Cached Medicine Technology:Unilife Successfully Completes Industrialization of Unifill Syringe 2Unilife Successfully Completes Industrialization of Unifill Syringe 3Unilife Successfully Completes Industrialization of Unifill Syringe 4Suneva Medical Announces Canadian Approval of Bellafill™ 2
(Date:7/28/2014)... Reinberg HealthDay Reporter MONDAY, ... and heart rhythm irregularities are more likely to get a ... In fact, the study of more than 16,000 people found ... likely to get a pacemaker than those without the memory-robbing ... why folks with dementia are so much more likely to ...
(Date:7/28/2014)... Dearborn, Michigan (PRWEB) July 28, 2014 ... from Drs. Harris, Birkhill, Wang, Songe and Associates, PC ... generations and countless tomorrows to come. , The ... group, responsible for more than $2.5 million in donations. ... the title sponsors for the Oakwood Women’s Healthcare Classic ...
(Date:7/28/2014)... Amy Norton HealthDay Reporter ... are commonly done to relieve sleep apnea in children, but ... weight gain -- especially if they,re already overweight. The ... factor for a range of health problems -- including, ironically, ... who need it. Instead, they said, doctors and parents ...
(Date:7/28/2014)... July 28, 2014 Lourdes Health System ... access and reduced wait times for veterans needing medical ... systems in the state—and the only one in Camden, ... Patient-Centered Community Care program (PC3). PC3 gives veterans access ... hospital cannot provide services due to lack of available ...
(Date:7/28/2014)... The American Society of ... engaged in the field of organ transplantation, today ... Immunology Research Network (TIRN), a professional network ... modern organ transplantation continues to diversify, AST determined ... more opportunities for physicians, scientists and researchers to ...
Breaking Medicine News(10 mins):Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 2Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 3Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 2Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 3
... relative diagnosed before 50 adds to likelihood of diagnosis, study ... a family member who had pancreatic cancer before age 50 ... study has found. , Researchers already knew that people with ... than others to develop the disease, but it wasn,t clear ...
... as 50 per cent of people bring their work home ... University of Toronto that describes the stress associated with work-life ... the extent to which work was interfering with personal time ... Sociology professor Scott Schieman (UofT) and his coauthors Melissa Milkie ...
... , WATERTOWN, Mass. , Jan. 12 ... and cardiovascular system is also good for the brain, according ... has been braving cold temperatures to get in shape for ... organizers are encouraging others to keep in shape as well. ...
... Jan. 12 Retrofitness, the can,t-be-duplicated 1980s-themed fitness chain, has ... Atlanta . , The New Jersey -based fitness franchisor ... by March, the first of a projected 15 to 20 ... locations open in eight states with 80 more clubs in various ...
... the most common form of renal cell cancer, according to research ... . US researchers found that obese patients with kidney tumours ... cell cancer (RCC) than patients with a body mass index (BMI) ... cent for every extra BMI point. The team at the ...
... Institutes of Health and the city of Washington, D.C. ... a collaborative research initiative between NIH and the D.C. ... new HIV infections in the city, improve the health ... the city,s response to the HIV/AIDS epidemic. The partnership ...
Cached Medicine News:Health News:With Pancreatic Cancer, Age Factors Into Familial Risk 2Health News:When work interferes with life 2Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 2Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 3Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 4Health News:Hot Fitness Concept Comes to Atlanta 2Health News:Obesity linked to common form of kidney cancer and each extra BMI point increases risk 2Health News:NIH and D.C. Department of Health team up to combat District's HIV/AIDS epidemic 2Health News:NIH and D.C. Department of Health team up to combat District's HIV/AIDS epidemic 3Health News:NIH and D.C. Department of Health team up to combat District's HIV/AIDS epidemic 4Health News:NIH and D.C. Department of Health team up to combat District's HIV/AIDS epidemic 5
... cannula with 30 gauge, 4.76 mm tip is ... Cannula is attached to a luer lock high ... inch long), for use with high viscosity substances. ... using visco elastic materials. Flattened, angled tip of ...
20 gauge x 25 mm cannula with 30 degree x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub. 10 per box....
Developed for oculoplastic procedures for corneal and scleral protection. Dimensions enable protector to rest on the sclera and not on the cornea. Easily removed with Bishop-Harmon Forceps. Individua...
The moist air humidifying chamber is designed for the infusion of humidified air during phakic fluid air exchange. Sterile single-use. 10 per box. Most popular size or model....
Medicine Products: